Frons Pharma And Life Sciences Private Limited
Founded in 2023 and headquartered in Uttar Pradesh, India.
2023 | Lucknow, Uttar Pradesh (India) | Active
Frons Pharma And Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 8 Months
About Frons Pharma And Life Sciences
Frons Pharma And Life Sciences Private Limited (FPALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 June 2023 (One year and eight months 26 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priyanka Thakur, Praveen Kumar, and Sharda Devi serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21001UP2023PTC183327
- Company No.
183327
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Paper
Who are the key members and board of directors at Frons Pharma And Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyanka Thakur  | Director | 02-Jun-2023 | Current |
| Praveen Kumar | Director | 02-Jun-2023 | Current |
| Sharda Devi | Director | 23-Aug-2024 | Current |
Financial Performance of Frons Pharma And Life Sciences.
Enhance accessibility to Frons Pharma And Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Frons Pharma And Life Sciences?
Unlock access to Frons Pharma And Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Nvpt Enterprises Llp
Priyanka Thakur is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Frons Pharma And Life Sciences?
Unlock and access historical data on people associated with Frons Pharma And Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Frons Pharma And Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Frons Pharma And Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
